» Articles » PMID: 37052738

Radiomics Model to Classify Mammary Masses Using Breast DCE-MRI Compared to the BI-RADS Classification Performance

Overview
Publisher Springer
Specialty Radiology
Date 2023 Apr 13
PMID 37052738
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent advanced in radiomics analysis could help to identify breast cancer among benign mammary masses. The aim was to create a radiomics signature using breast DCE-MRI extracted features to classify tumors and to compare the performances with the BI-RADS classification.

Material And Methods: From September 2017 to December 2019 images, exams and records from consecutive patients with mammary masses on breast DCE-MRI and available histology from one center were retrospectively reviewed (79 patients, 97 masses). Exclusion criterion was malignant uncertainty. The tumors were split in a train-set (70%) and a test-set (30%). From 14 kinetics maps, 89 radiomics features were extracted, for a total of 1246 features per tumor. Feature selection was made using Boruta algorithm, to train a random forest algorithm on the train-set. BI-RADS classification was recorded from two radiologists.

Results: Seventy-seven patients were analyzed with 94 tumors, (71 malignant, 23 benign). Over 1246 features, 17 were selected from eight kinetic maps. On the test-set, the model reaches an AUC = 0.94 95 CI [0.85-1.00] and a specificity of 33% 95 CI [10-70]. There were 43/94 (46%) lesions BI-RADS4 (4a = 12/94 (13%); 4b = 9/94 (10%); and 4c = 22/94 (23%)). The BI-RADS score reached an AUC = 0.84 95 CI [0.73-0.95] and a specificity of 17% 95 CI [3-56]. There was no significant difference between the ROC curves for the model or the BI-RADS score (p = 0.19).

Conclusion: A radiomics signature from features extracted using breast DCE-MRI can reach an AUC of 0.94 on a test-set and could provide as good results as BI-RADS to classify mammary masses.

Citing Articles

Quantitative DCE Dynamics on Transformed MR Imaging Discriminates Clinically Significant Prostate Cancer.

Wei Z, Iluppangama M, Qi J, Choi J, Yu A, Gage K Cancer Control. 2024; 31:10732748241298539.

PMID: 39545376 PMC: 11565616. DOI: 10.1177/10732748241298539.


An updated overview of radiomics-based artificial intelligence (AI) methods in breast cancer screening and diagnosis.

Elahi R, Nazari M Radiol Phys Technol. 2024; 17(4):795-818.

PMID: 39285146 DOI: 10.1007/s12194-024-00842-6.


Are we ready to stratify BI-RADS 4 MRI lesions?.

de Oliveira T Radiol Bras. 2024; 56(6):V-VI.

PMID: 38504812 PMC: 10948156. DOI: 10.1590/0100-3984.2023.56.6e1.

References
1.
Pinker K, Helbich T, Morris E . The potential of multiparametric MRI of the breast. Br J Radiol. 2016; 90(1069):20160715. PMC: 5605035. DOI: 10.1259/bjr.20160715. View

2.
Kursa M . Robustness of Random Forest-based gene selection methods. BMC Bioinformatics. 2014; 15:8. PMC: 3897925. DOI: 10.1186/1471-2105-15-8. View

3.
Wan T, Bloch B, Plecha D, Thompson C, Gilmore H, Jaffe C . A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores. Sci Rep. 2016; 6:21394. PMC: 4757835. DOI: 10.1038/srep21394. View

4.
Kim J, Ko E, Lim Y, Lee K, Han B, Ko E . Breast Cancer Heterogeneity: MR Imaging Texture Analysis and Survival Outcomes. Radiology. 2016; 282(3):665-675. DOI: 10.1148/radiol.2016160261. View

5.
Kuhl C, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J . Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology. 1999; 211(1):101-10. DOI: 10.1148/radiology.211.1.r99ap38101. View